Answer
Remicade (infliximab) is contraindicated in patients with moderate or severe heart failure (NYHA class III/IV).
Sources for this answer
- Remicade 100mg powder for concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 75Document updated
Sources checked